142 related articles for article (PubMed ID: 32363791)
1. Structure-Activity Relationship Study of a Potent α-Thrombin Binding Aptamer Incorporating Hexitol Nucleotides.
De Fenza M; Eremeeva E; Troisi R; Yang H; Esposito A; Sica F; Herdewijn P; D'Alonzo D; Guaragna A
Chemistry; 2020 Aug; 26(43):9589-9597. PubMed ID: 32363791
[TBL] [Abstract][Full Text] [Related]
2. Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer.
Troisi R; Napolitano V; Spiridonova V; Russo Krauss I; Sica F
Nucleic Acids Res; 2018 Dec; 46(22):12177-12185. PubMed ID: 30357392
[TBL] [Abstract][Full Text] [Related]
3. Cation Coordination Alters the Conformation of a Thrombin-Binding G-Quadruplex DNA Aptamer That Affects Inhibition of Thrombin.
Zavyalova E; Tagiltsev G; Reshetnikov R; Arutyunyan A; Kopylov A
Nucleic Acid Ther; 2016 Oct; 26(5):299-308. PubMed ID: 27159247
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analysis of the simultaneous binding of two duplex/quadruplex aptamers to human α-thrombin.
Troisi R; Balasco N; Santamaria A; Vitagliano L; Sica F
Int J Biol Macromol; 2021 Jun; 181():858-867. PubMed ID: 33864869
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight.
Riccardi C; Meyer A; Vasseur JJ; Cavasso D; Russo Krauss I; Paduano L; Morvan F; Montesarchio D
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485818
[TBL] [Abstract][Full Text] [Related]
6. Rapid Complexation of Aptamers by Their Specific Antidotes.
Stoll H; Steinle H; Wilhelm N; Hann L; Kunnakattu SJ; Narita M; Schlensak C; Wendel HP; Avci-Adali M
Molecules; 2017 Jun; 22(6):. PubMed ID: 28594360
[TBL] [Abstract][Full Text] [Related]
7. Highly stable hexitol based XNA aptamers targeting the vascular endothelial growth factor.
Eremeeva E; Fikatas A; Margamuljana L; Abramov M; Schols D; Groaz E; Herdewijn P
Nucleic Acids Res; 2019 Jun; 47(10):4927-4939. PubMed ID: 30968117
[TBL] [Abstract][Full Text] [Related]
8. Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications.
Avino A; Fabrega C; Tintore M; Eritja R
Curr Pharm Des; 2012; 18(14):2036-47. PubMed ID: 22376107
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethyl-2'-deoxyuridine residues in the thrombin binding aptamer: investigating anticoagulant activity by making a tiny chemical modification.
Virgilio A; Petraccone L; Scuotto M; Vellecco V; Bucci M; Mayol L; Varra M; Esposito V; Galeone A
Chembiochem; 2014 Nov; 15(16):2427-34. PubMed ID: 25214456
[TBL] [Abstract][Full Text] [Related]
10. Module-activity relationship of G-quadruplex based DNA aptamers for human thrombin.
Zavyalova E; Golovin A; Pavlova G; Kopylov A
Curr Med Chem; 2013; 20(38):4836-43. PubMed ID: 24083606
[TBL] [Abstract][Full Text] [Related]
11. Alpha-Deoxyguanosine to Reshape the Alpha-Thrombin Binding Aptamer.
Kolganova NA; Tsvetkov VB; Stomakhin AA; Surzhikov SA; Timofeev EN; Varizhuk IV
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176113
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the selectivity of thrombin-binding aptamers for thrombin titration in murine plasma.
Trapaidze A; Hérault JP; Herbert JM; Bancaud A; Gué AM
Biosens Bioelectron; 2016 Apr; 78():58-66. PubMed ID: 26594887
[TBL] [Abstract][Full Text] [Related]
13. Duplex/quadruplex oligonucleotides: Role of the duplex domain in the stabilization of a new generation of highly effective anti-thrombin aptamers.
Russo Krauss I; Napolitano V; Petraccone L; Troisi R; Spiridonova V; Mattia CA; Sica F
Int J Biol Macromol; 2018 Feb; 107(Pt B):1697-1705. PubMed ID: 29024684
[TBL] [Abstract][Full Text] [Related]
14. Micellar Thrombin-Binding Aptamers: Reversible Nanoscale Anticoagulants.
Roloff A; Carlini AS; Callmann CE; Gianneschi NC
J Am Chem Soc; 2017 Nov; 139(46):16442-16445. PubMed ID: 29135251
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and in vitro activity of thrombin-binding DNA aptamers with triazole internucleotide linkages.
Varizhuk AM; Tsvetkov VB; Tatarinova ON; Kaluzhny DN; Florentiev VL; Timofeev EN; Shchyolkina AK; Borisova OF; Smirnov IP; Grokhovsky SL; Aseychev AV; Pozmogova GE
Eur J Med Chem; 2013 Sep; 67():90-7. PubMed ID: 23850569
[TBL] [Abstract][Full Text] [Related]
16. Genetically Encoded, Functional Single-Strand RNA Origami: Anticoagulant.
Krissanaprasit A; Key C; Fergione M; Froehlich K; Pontula S; Hart M; Carriel P; Kjems J; Andersen ES; LaBean TH
Adv Mater; 2019 May; 31(21):e1808262. PubMed ID: 30972819
[TBL] [Abstract][Full Text] [Related]
17. Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.
Buff MC; Schäfer F; Wulffen B; Müller J; Pötzsch B; Heckel A; Mayer G
Nucleic Acids Res; 2010 Apr; 38(6):2111-8. PubMed ID: 20007153
[TBL] [Abstract][Full Text] [Related]
18. Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site.
Kolganova NA; Tsvetkov VB; Smirnov IP; Timofeev EN
Nucleic Acid Ther; 2019 Aug; 29(4):208-217. PubMed ID: 30864877
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic and biological evaluation of a thrombin binding aptamer modified with several unlocked nucleic acid (UNA) monomers and a 2'-C-piperazino-UNA monomer.
Jensen TB; Henriksen JR; Rasmussen BE; Rasmussen LM; Andresen TL; Wengel J; Pasternak A
Bioorg Med Chem; 2011 Aug; 19(16):4739-45. PubMed ID: 21795054
[TBL] [Abstract][Full Text] [Related]
20. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.
Rangnekar A; Zhang AM; Li SS; Bompiani KM; Hansen MN; Gothelf KV; Sullenger BA; LaBean TH
Nanomedicine; 2012 Jul; 8(5):673-81. PubMed ID: 21889476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
